💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Champions Oncology Inc (CSBR)

NASDAQ
Currency in USD
Disclaimer
4.890
+0.610(+14.25%)
Closed
After Hours
4.880-0.010(-0.204%)
CSBR Scorecard
Full Analysis
Net income is expected to grow this year
Fair Value
Day's Range
4.4104.890
52 wk Range
3.6007.130
Prev. Close
4.89
Open
4.41
Day's Range
4.41-4.89
52 wk Range
3.6-7.13
Volume
76,253
Average Volume (3m)
49,182
1-Year Change
-8.6%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
CSBR Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
6.000
Upside
+22.699%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week
Show more

Champions Oncology Inc Company Profile

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Compare CSBR to Peers and Sector

Metrics to compare
CSBR
Peers
Sector
Relationship
P/E Ratio
−17.1x−3.3x−0.6x
PEG Ratio
−0.36−0.150.00
Price/Book
−175.2x2.9x2.6x
Price / LTM Sales
1.1x2.9x3.1x
Upside (Analyst Target)
22.7%13.8%55.0%
Fair Value Upside
Unlock−0.4%6.8%Unlock

FAQ

What Is the Champions Oncology (CSBR) Stock Price Today?

The Champions Oncology stock price today is 4.89

What Stock Exchange Does Champions Oncology Trade On?

Champions Oncology is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Champions Oncology?

The stock symbol for Champions Oncology is "CSBR."

What Is the Champions Oncology Market Cap?

As of today, Champions Oncology market cap is 66.47M.

What is Champions Oncology Earnings Per Share?

The Champions Oncology EPS is -0.25.

What Is the Next Champions Oncology Earnings Date?

Champions Oncology will release its next earnings report on 15 Dec 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.